Editas Medicine IncEigentümerstruktur
| Preis (2026-07-29) | 52W Hoch | 52W Tief |
| 2.6 USD | 4,537 USD | 1,66 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 5,778 USD | 4 | 1 | 8 | 2 | 0 |
| #Shares | Short [%] | Short Ratio |
| 153.461.838 | 14,49 | 7,51 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Editas Medicine Inc
Mitarbeiter 87
Handelsplatz NASDAQ
Ticker Symbol EDIT
IPO Datum 2016-02-03
Adresse 11 Hurley Street, Cambridge, MA, United States, 02141
Webseite https://www.editasmedicine.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Gilmore O'Neill M.D. | President, CEO & Director |
| 2 | Ms. Amy Parison | Senior VP & CFO |
| 3 | Dr. Linda C. Burkly Ph.D. | Executive VP & Chief Scientific Officer |
| 4 | Dr. Feng Zhang Ph.D. | Co-Founder & Scientific Advisory Board Member |
| 5 | Dr. George McDonald Church Ph.D. | Co-Founder & Scientific Advisory Board Member |
| 6 | Mr. Gregory Whitehead | Executive VP and Chief Technical & Quality Officer |
| 7 | Mr. Damien Grierson J.D. | Senior VP, General Counsel & Corporate Secretary |
| 8 | Mr. Tom Love | Vice President of People |
| 9 | Mr. Frank Panaccio | Senior VP & Chief Business Officer |
| 10 | Ms. Brieana Buckley | Senior Vice President of Development and Program Leadership |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 2 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 4 | Renaissance Technologies Corp | 0,00% | 0,00 Mio. USD |
| 5 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 6 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 7 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 8 | Nuveen, LLC | 0,00% | 0,00 Mio. USD |
| 9 | JPMorgan Chase & Co | 0,00% | 0,00 Mio. USD |
| 10 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |
| 11 | Opaleye Management Inc | 0,00% | 0,00 Mio. USD |
| 12 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 13 | Acadian Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 14 | AQR Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 15 | Two Sigma Advisers, LLC | 0,00% | 0,00 Mio. USD |
| 16 | Kennedy Capital Management Inc | 0,00% | 0,00 Mio. USD |
| 17 | Charles Schwab Investment Management Inc | 0,00% | 0,00 Mio. USD |
| 18 | Northern Trust Corp | 0,00% | 0,00 Mio. USD |
| 19 | Mackenzie Investments | 0,00% | 0,00 Mio. USD |
| 20 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |